BCISE Trademark

Trademark Overview

On Wednesday, April 1, 2015, a trademark application was filed for BCISE with the United States Patent and Trademark Office. The USPTO has given the BCISE trademark a serial number of 86584499. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Saturday, May 18, 2024. This trademark is owned by AstraZeneca Pharmaceuticals LP. The BCISE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of metabolic diseases and disorders
bcise

General Information

Serial Number86584499
Word MarkBCISE
Filing DateWednesday, April 1, 2015
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateSaturday, May 18, 2024
Registration Number5492498
Registration DateTuesday, June 12, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 1, 2016

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of metabolic diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, April 11, 2015
Primary Code005
First Use Anywhere DateThursday, November 30, 2017
First Use In Commerce DateThursday, November 30, 2017

Trademark Owner History

Party NameAstraZeneca Pharmaceuticals LP
Party Type30 - Original Registrant
Legal Entity Type13 - Limited Partnership
AddressWilmington, DE 19803
Party NameAstraZeneca Pharmaceuticals LP
Party Type20 - Owner at Publication
Legal Entity Type13 - Limited Partnership
AddressWilmington, DE 19850
Party NameAstraZeneca Pharmaceuticals LP
Party Type10 - Original Applicant
Legal Entity Type13 - Limited Partnership
AddressWilmington, DE 19850

Trademark Events

Event DateEvent Description
Sunday, July 12, 2015NON-FINAL ACTION E-MAILED
Saturday, April 4, 2015NEW APPLICATION ENTERED
Saturday, April 11, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, July 8, 2015ASSIGNED TO EXAMINER
Sunday, July 12, 2015NON-FINAL ACTION WRITTEN
Sunday, July 12, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, January 19, 2016NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, December 16, 2015TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, December 16, 2015ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, December 22, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, January 12, 2016ASSIGNED TO LIE
Tuesday, January 12, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, January 12, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, January 19, 2016EXAMINERS AMENDMENT -WRITTEN
Tuesday, January 19, 2016EXAMINERS AMENDMENT E-MAILED
Tuesday, January 19, 2016EXAMINER'S AMENDMENT ENTERED
Wednesday, October 5, 2016SOU EXTENSION 1 GRANTED
Tuesday, January 19, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 27, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, February 10, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 1, 2016PUBLISHED FOR OPPOSITION
Tuesday, March 1, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 26, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, October 5, 2016SOU TEAS EXTENSION RECEIVED
Wednesday, October 5, 2016SOU EXTENSION 1 FILED
Tuesday, April 3, 2018TEAS STATEMENT OF USE RECEIVED
Friday, October 7, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 4, 2017SOU TEAS EXTENSION RECEIVED
Tuesday, April 4, 2017SOU EXTENSION 2 FILED
Tuesday, April 4, 2017SOU EXTENSION 2 GRANTED
Friday, April 7, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 18, 2017SOU TEAS EXTENSION RECEIVED
Wednesday, October 18, 2017SOU EXTENSION 3 FILED
Wednesday, October 18, 2017SOU EXTENSION 3 GRANTED
Friday, October 20, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 22, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, April 3, 2018USE AMENDMENT FILED
Friday, April 20, 2018STATEMENT OF USE PROCESSING COMPLETE
Thursday, April 19, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, May 8, 2018ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, May 9, 2018NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, June 12, 2018REGISTERED-PRINCIPAL REGISTER
Thursday, July 22, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, July 22, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, July 22, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, July 22, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, June 12, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, November 15, 2023TEAS SECTION 8 & 15 RECEIVED
Saturday, May 18, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Saturday, May 18, 2024REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Saturday, May 18, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

Related Keywords

bcise diseases disorders metabolic treatment preparations substances pharmaceutical